Nascent Biotech (OTCMKTS:NBIO) Share Price Crosses Below 50-Day Moving Average – What’s Next?

by · The Cerbat Gem

Nascent Biotech, Inc. (OTCMKTS:NBIO – Get Free Report) passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.06 and traded as low as $0.06. Nascent Biotech shares last traded at $0.08, with a volume of 106,144 shares trading hands.

Nascent Biotech Trading Up 21.3 %

The company’s fifty day simple moving average is $0.06 and its two-hundred day simple moving average is $0.07.

About Nascent Biotech

(Get Free Report)

Nascent Biotech, Inc, a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer.

Read More